203 related articles for article (PubMed ID: 22070248)
1. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury.
Manabe K; Kamihata H; Motohiro M; Senoo T; Yoshida S; Iwasaka T
Eur J Clin Invest; 2012 May; 42(5):557-63. PubMed ID: 22070248
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
[TBL] [Abstract][Full Text] [Related]
3. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery.
Katagiri D; Doi K; Honda K; Negishi K; Fujita T; Hisagi M; Ono M; Matsubara T; Yahagi N; Iwagami M; Ohtake T; Kobayashi S; Sugaya T; Noiri E
Ann Thorac Surg; 2012 Feb; 93(2):577-83. PubMed ID: 22269724
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
[TBL] [Abstract][Full Text] [Related]
5. Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care.
Doi K; Noiri E; Sugaya T
Curr Opin Crit Care; 2010 Dec; 16(6):545-9. PubMed ID: 20736829
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.
Doi K; Negishi K; Ishizu T; Katagiri D; Fujita T; Matsubara T; Yahagi N; Sugaya T; Noiri E
Crit Care Med; 2011 Nov; 39(11):2464-9. PubMed ID: 21705884
[TBL] [Abstract][Full Text] [Related]
7. Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.
Katoh H; Nozue T; Kimura Y; Nakata S; Iwaki T; Kawano M; Kawashiri MA; Michishita I; Yamagishi M
Heart Vessels; 2014 Mar; 29(2):191-7. PubMed ID: 23604313
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis.
Mou S; Wang Q; Li J; Shi B; Ni Z
Clin Chim Acta; 2012 Jan; 413(1-2):187-91. PubMed ID: 21958699
[TBL] [Abstract][Full Text] [Related]
9. Urinary fatty acid binding protein in renal disease.
Kamijo-Ikemori A; Sugaya T; Kimura K
Clin Chim Acta; 2006 Dec; 374(1-2):1-7. PubMed ID: 16860300
[TBL] [Abstract][Full Text] [Related]
10. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury.
Doi K; Noiri E; Maeda-Mamiya R; Ishii T; Negishi K; Hamasaki Y; Fujita T; Yahagi N; Koide H; Sugaya T; Nakamura T
Crit Care Med; 2010 Oct; 38(10):2037-42. PubMed ID: 20657273
[TBL] [Abstract][Full Text] [Related]
11. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.
Maioli M; Toso A; Leoncini M; Gallopin M; Musilli N; Bellandi F
Circulation; 2012 Jun; 125(25):3099-107. PubMed ID: 22592896
[TBL] [Abstract][Full Text] [Related]
12. [Effects of intravascular contrast media on urinary excretion of liver fatty acid-binding protein].
Ohta S; Ishimitsu T; Minami J; Ono H; Matsuoka H
Nihon Jinzo Gakkai Shi; 2005; 47(4):437-44. PubMed ID: 15971886
[TBL] [Abstract][Full Text] [Related]
13. Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H
Am J Nephrol; 2006; 26(3):276-80. PubMed ID: 16772708
[TBL] [Abstract][Full Text] [Related]
14. Comparison of risk factors for contrast-induced acute kidney injury between patients with and without diabetes.
Pakfetrat M; Nikoo MH; Malekmakan L; Tabande M; Roozbeh J; Ganbar Ali RJ; Khajehdehi P
Hemodial Int; 2010 Oct; 14(4):387-92. PubMed ID: 20796046
[TBL] [Abstract][Full Text] [Related]
15. Serum creatinine measurement immediately after cardiac surgery and prediction of acute kidney injury.
Ho J; Reslerova M; Gali B; Nickerson PW; Rush DN; Sood MM; Bueti J; Komenda P; Pascoe E; Arora RC; Rigatto C
Am J Kidney Dis; 2012 Feb; 59(2):196-201. PubMed ID: 21967775
[TBL] [Abstract][Full Text] [Related]
16. Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis.
Liu Y; Guo W; Zhang J; Xu C; Yu S; Mao Z; Wu J; Ye C; Mei C; Dai B
Am J Kidney Dis; 2013 Dec; 62(6):1058-67. PubMed ID: 23830182
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of tubular and podocyte biomarkers in acute kidney injury.
Matsui K; Kamijo-Ikemori A; Hara M; Sugaya T; Kodama T; Fujitani S; Taira Y; Yasuda T; Kimura K
Clin Exp Nephrol; 2011 Apr; 15(2):220-5. PubMed ID: 21153750
[TBL] [Abstract][Full Text] [Related]
18. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
Garcia S; Ko B; Adabag S
Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
[TBL] [Abstract][Full Text] [Related]
19. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
[TBL] [Abstract][Full Text] [Related]
20. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease.
Nakamura T; Sugaya T; Kawagoe Y; Suzuki T; Inoue T; Node K
Am J Nephrol; 2006; 26(1):82-6. PubMed ID: 16534182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
